Invasive Coronary Angiography Early in Ischemic Heart Failure
NCT ID: NCT04245605
Last Updated: 2022-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2994 participants
OBSERVATIONAL
2010-04-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164
Acute Myocardial Infarction Quality Assurance Project
NCT02399891
Characterization of Ischemia Related Changes in Esophageal Electrocardiography
NCT01390155
Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.
NCT02014701
Functional Assessment of Myocardial Ischemia by Intracoronary Electrocardiogram
NCT03985241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early angiography
Patients admitted to hospital with acute heart failure undergoing coronary angiography within 14 days of hospital admission
Coronary angiography
Coronary angiogram performed either in hospital or post-discharge, within 14 days after initial hospital presentation with heart failure
Control
Patients admitted to hospital with acute heart failure not undergoing coronary angiography within 14 days
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coronary angiography
Coronary angiogram performed either in hospital or post-discharge, within 14 days after initial hospital presentation with heart failure
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Coronary angiogram or revascularization within previous 3 months before admission
* Nonresidents of Ontario, invalid health card number
* HF diagnosed after admission
* Admission BNP or NT-proBNP not diagnostic of HF
* Died within 14 days of admission
* Palliative within 6 months prior to hospital admission
* Elevated creatinine concentration
* Documented anaphylactic contrast allergy
* Ischemic or hemorrhagic stroke within 3 months prior to admission
* Highest category of Hospital Frailty Risk Score
* Active severe bleeding at time of hospital admission
* Absolute platelet count \< 20
* Metastatic cancer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Clinical Evaluative Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Douglas Lee
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Douglas Lee, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
ICES
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Health Network
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.